JSC “Farmak” will defend its intellectual property rights to the well-known trademark Corvalol Corvalolum at the hearing of the Grand Chamber of the Supreme Court of Ukraine scheduled for June 25, 2019.
JSC “Farmak” stands for a civilized competition and defends its rights to the well-known trademark Corvalol Corvalolum.
The hearing will be held at 04:00 p.m. at 8 Pylypa Orlyka Str., at the room of the Supreme Court.
It should be reminded that having examined the appeal of Pharmaceutical Firm “Darnitsa”, Kyiv Commercial Court of Appeal quashed the decision of the Appeals Chamber of the Ministry of Economic Development and Trade on the recognition of CORVALOL CORVALOLUM as well-known trademark.
The motions filed by both the Ministry of Economic Development and Trade as the defendant, and JSC “Farmak” as the third party were dismissed, evidencing biased proceedings in the appellate instance.
Historically, Farmak has owned the trademark “CORVALOL”, manufactured since 1960. “Corvalol” was developed in 1960 by Lomonosov Kyiv Chemical and Pharmaceutical Plant, the successor of which is JSC “Farmak”.
JSC “Farmak” has been established on the basis of Lomonosov Kyiv Chemical and Pharmaceutical Plant in 1925, specialized in manufacturing of pharmaceutical substances and radiopaque contrast agents in the territory of the former Soviet Union.
A new stage of the company’s development began after the transformation of the chemical plant into a robust pharmaceutical company manufacturing finished dosage forms in 1995.
Preparation for manufacturing of Corvalol was initiated by Lomonosov Kyiv Chemical and Pharmaceutical Plant, the successor of which is JSC “Farmak”.
The medicinal product was developed by Senior Chemist V.Ya. Yakovleva.
The first batch of Corvalol was released under the order of Lomonosov Kyiv Chemical and Pharmaceutical Plant dated October 15, 1960.
Since then, Lomonosov Kyiv Chemical and Pharmaceutical Plant has been the only manufacturer of Corvalol in the territory of the former USSR.
Since 1991, JSC “Farmak” has been the only manufacturer of this medicinal product in the former Soviet Union.
Furthermore, Corvalol trademark is protected in 15 countries of Europe and Central Asia: Germany, Poland, Lithuania, Estonia, Latvia, Belarus, Moldova, Romania, Bulgaria, Turkmenistan, Armenia, Georgia, Azerbaijan, Tajikistan, Kyrgyzstan, and Kazakhstan.
The use of the trademark Corvalol Corvalolum is generally confirmed by packaging for the period from 1991 to 2001 inclusive.
The pharmaceutical company JSC “Farmak” considers the possibility of launching the manufacture of products, in particular, diagnostic test kits, to combat coronavirus spread. “Now we analyse the possibility of arranging the release of supportive care products, disinfectants and antiseptics, diagnostic test kits, protective medical products, including masks, ...
Farmak reinvests 95% of its profits in the development. “We have never paid more than 5% of our profits as dividends. We have reinvested everything in the development. Due to this, Farmak’s capitalization can be estimated at $850 million to $1 billion today. If I sell the shares that I hold, I will earn a […]
The Memorandum is aimed at developing the mutual cooperation in the implementation of the state programs of the Republic of Uzbekistan for the further development of the national pharmaceutical industry. “We know the Uzbek market well and we are committed to develop cooperation. Farmak has been present in Uzbekistan since 2004. The residents of this [&hellip...